Company / Capital Returned to Shareholders
Humana Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$581.0M
FY2025
5-year range
$433.0M / $2.1B
FY2021-FY2025
Trend
-53.4%
vs FY2024
Sector context
#33 of 108
Health Care
What the data says
At $581M, Humana's capital returned to shareholders ranks #33 of 108 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $281M in FY2016 to $3.6B in FY2019.
Based on SEC 10-K filings.
$581M in FY2025 with a 5-year CAGR of -23.0%.
Improved from $433M to $581M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -35.3%
- 5-Year CAGR
- -23.0%
- 10-Year CAGR
- -
Sector benchmark
#33 of 108 in Health CareTop 31% of 108This company $581.0M Sector average $765.5M
▼
-24.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -23.0%, indicating a declining trend.
- In FY2025, capital returned to shareholders decreased 53.4% year-over-year.
- Ranks #33 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.80 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $581.0M | -53.4% |
| FY2024 | $1.2B | +188.2% |
| FY2023 | $433.0M | -79.8% |
| FY2022 | $2.1B | +394.9% |
| FY2021 | $433.0M | -79.8% |
| FY2020 | $2.1B | -40.2% |
| FY2019 | $3.6B | +164.6% |
| FY2018 | $1.4B | +143.3% |
| FY2017 | $557.0M | +98.2% |
| FY2016 | $281.0M | -59.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026